Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001104659-24-109233
Filing Date
2024-10-16
Accepted
2024-10-16 16:35:56
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B5 tm2426251-1_424b5.htm 424B5 524681
2 GRAPHIC lg_capricor-4c.jpg GRAPHIC 19299
  Complete submission text file 0001104659-24-109233.txt   552646
Mailing Address 8840 WILSHIRE BLVD 2ND FLOOR BEVERLY HILLS CA 90211
Business Address 8840 WILSHIRE BLVD 2ND FLOOR BEVERLY HILLS CA 90211 (310) 358-3200
CAPRICOR THERAPEUTICS, INC. (Filer) CIK: 0001133869 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-280229 | Film No.: 241375030
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)